Leukemia inhibitory factor, glycodelin, and HOXA-10 in gestational diabetes

被引:0
作者
Aydin, Y. [1 ]
Uludag, S. [2 ]
Atis, A. [4 ]
Ilvan, S. [3 ,4 ]
机构
[1] Medicana Hosp, Obstet & Gynecol, Istanbul, Turkey
[2] Cerrahpasa Med Fac, Obstet & Gynecol, Istanbul, Turkey
[3] Cerrahpasa Med Fac, Histopathol, Istanbul, Turkey
[4] Kanuni Sultan Suleyman Training & Res Hosp, Obstet & Gynecol, Istanbul, Turkey
关键词
Gestational diabetes; Glycodelin; HOXA-10; Leukemia inhibitory factor; EXPRESSION; IMPLANTATION; DIFFERENTIATION; PROGESTERONE; ENDOMETRIUM; TROPHOBLAST; PROTEIN-14; PLASMA; MICE;
D O I
10.12891/ceog4532.2019
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Purpose of investigation: The authors aimed to localize glycodelin, leukemia inhibitory factor (LIF), and HOXA-10 in term placentas and study the relationship between these markers and maternal gestational diabetes. Materials and Methods: Following labor, placentas from 12 pregnant women with gestational diabetes and 15 healthy pregnant women were collected, fixed, and paraffin-embedded, and immunohistochemical studies were performed. Two independent researchers examined the specimens under light microscopy. Immunoreactive scores were calculated and compared. Results: Glycodelin and HOXA-10 were stained in the decidua, and LIF was stained both in the trophoblast and in the decidua of term placentas. The three markers' immunoreactive scores were not different between pregnant women with gestational diabetes and the healthy controls. Conclusion: Glycodelin and HOXA-10 were produced by maternal decidual cells; LIF was produced by both trophoblasts and maternal decidual cells. Glycodelin, HOXA-10, and LIF are not related to the pathophysiology of gestational diabetes.
引用
收藏
页码:539 / 541
页数:3
相关论文
共 23 条
[1]  
Benson GV, 1996, DEVELOPMENT, V122, P2687
[2]   THE RADIOIMMUNOASSAY OF HUMAN PLACENTAL PROTEIN-14 (PP14) [J].
BOLTON, AE ;
CHAPMAN, MG ;
STOKER, RJ ;
ANDREW, CE ;
WASS, D ;
BOHN, H .
CLINICA CHIMICA ACTA, 1983, 135 (03) :283-291
[3]   Changes in gene expression during the early to mid-luteal (receptive phase) transition in human endometrium detected by high-density microarray screening [J].
Carson, DD ;
Lagow, E ;
Thathiah, A ;
Al-Shami, R ;
Farach-Carson, MC ;
Vernon, M ;
Yuan, LW ;
Fritz, MA ;
Lessey, B .
MOLECULAR HUMAN REPRODUCTION, 2002, 8 (09) :871-879
[4]   Leukemia inhibitory factor can substitute for nidatory estrogen and is essential to inducing a receptive uterus for implantation but is not essential for subsequent embryogenesis [J].
Chen, JR ;
Cheng, JG ;
Shatzer, T ;
Sewell, L ;
Hernandez, L ;
Stewart, CL .
ENDOCRINOLOGY, 2000, 141 (12) :4365-4372
[5]   Uterine Msx-1 and Wnt4 signaling becomes aberrant in mice with the loss of leukemia inhibitory factor or Hoxa-10: Evidence for a novel cytokine-homeobox-Wnt signaling in implantation [J].
Daikoku, T ;
Song, H ;
Guo, Y ;
Riesewijk, A ;
Mosselman, S ;
Das, SK ;
Dey, SK .
MOLECULAR ENDOCRINOLOGY, 2004, 18 (05) :1238-1250
[6]   Regulation of homeobox A10 expression in the primate endometrium by progesterone and embryonic stimuli [J].
Godbole, G. B. ;
Modi, D. N. ;
Puri, C. P. .
REPRODUCTION, 2007, 134 (03) :513-523
[7]   Regulation of HOXA-10 and its expression in normal and abnormal endometrium [J].
Gui, YT ;
Zhang, JN ;
Yuan, LW ;
Lessey, BA .
MOLECULAR HUMAN REPRODUCTION, 1999, 5 (09) :866-873
[8]   Glycodelin reduces breast cancer xenograft growth in vivo [J].
Hautala, Laura C. ;
Koistinen, Riitta ;
Seppala, Markku ;
Butzow, Ralf ;
Stenman, Ulf-Hakan ;
Laakkonen, Pirjo ;
Koistinen, Hannu .
INTERNATIONAL JOURNAL OF CANCER, 2008, 123 (10) :2279-2284
[9]  
Hohn HP, 2000, MOL REPROD DEV, V57, P135
[10]   PLACENTAL PROTEIN-12 AND PROTEIN-14 IN PREECLAMPSIA [J].
HOWELL, RJS ;
ECONOMIDES, D ;
TEISNER, B ;
FARKAS, AG ;
CHARD, T .
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1989, 68 (03) :237-240